Cyberounds Logo
September 27, 2020 | LOGIN | REGISTER | HELP | 

email a friend print Bookmark and Share
Treatment-resistant Depression in Adolescents: Assessment and Management
CME credit is no longer available for this conference.
David Brent, M.D.

Dr. Brent is Academic Chief, Child and Adolescent Psychiatry, Western Psychiatric Institute and Clinic, Endowed Chair in Suicide Studies and Professor of Psychiatry, Pediatrics and Epidemiology, University of Pittsburgh School of Medicine

Within the past 12 months, Dr. Brent reports no commercial conflicts of interest.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.

Release Date: 09/21/2009
Termination Date: 09/21/2012

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Provide definitions of adequate treatment and treatment-resistant depression
  • Present a guide to the assessment of the adolescent with treatment- resistant depression
  • Describe a treatment approach to the adolescent with treatment-resistant depression.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity